Azenta Life Sciences

Azenta Life Sciences specializes in providing comprehensive life sciences services, focusing on genomics, cryogenic storage, automation, and informatics. The company delivers a reliable suite of cold-chain sample management solutions and genomic services tailored for drug development, clinical research, and advanced cell therapies. Its clientele includes leading pharmaceutical, biotech, academic, and healthcare institutions worldwide. Azenta operates through two main segments: Life Sciences Products and Life Sciences Services, with a significant portion of its revenue derived from the services segment. By enabling impactful breakthroughs, Azenta aims to accelerate the delivery of innovative therapies to the market.

Herman Cueto

Executive Vice President and CFO

4 past transactions

ziath

Acquisition in 2023
Ziath is a company focused on developing and manufacturing advanced 2D barcode readers specifically designed to decode datamatrix barcodes on sample tubes used in laboratories. Based in the United Kingdom, Ziath offers a range of products, including barcode scanners and a software management tool to enhance the efficiency and accuracy of laboratory sample handling. Their technology aims to streamline processes in laboratory environments by ensuring reliable identification and tracking of samples.

B Medical Systems

Acquisition in 2022
B Medical Systems is a manufacturer and global distributor based in Luxembourg, specializing in medical refrigeration, blood management, and vaccine cold chain equipment. With over 35 years of experience, the company develops innovative technologies that support hospitals, pharmacies, laboratories, pharmaceutical companies, and health organizations in the safe storage and transport of temperature-sensitive materials such as vaccines, blood, and medicines. Their product portfolio includes advanced vaccine transport systems with real-time monitoring capabilities, as well as reliable medical refrigeration solutions that cater to a range of temperature requirements. B Medical Systems is committed to ensuring low cost of ownership and operates through a global network of over 150 partners, enabling efficient customer support even in remote locations.

Barkey

Acquisition in 2022
Barkey Holding specializes in the manufacture of medical devices designed for use in various healthcare settings, including anesthesia, blood banks, intensive care units, operating theatres, and recovery rooms. The company is particularly known for its plasmatherm device, which provides a dry thawing solution for blood and blood products, as well as other cellular materials, such as CAR-T cells. This technology ensures consistent and even thawing, thereby maintaining high cell viability. Barkey's products are essential for hospitals, biotechnology firms, life sciences, and pharmaceutical companies, especially in preventing hypothermia during medical procedures.

Trans-Hit Biomarkers

Acquisition in 2020
Trans-Hit Biomarkers Inc. is a biospecimen procurement contract research organization based in Laval, Canada, established in 2009. The company specializes in providing access to a network of academic, hospital, and clinical sources for bio specimens and clinical samples. By collaborating with state-of-the-art academic biorepositories and clinical sites, Trans-Hit Biomarkers enables the biotechnology industry to effectively source the necessary materials for research purposes. As of December 2020, it operates as a subsidiary of Brooks Life Science Systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.